Biotech company that leverages AI‑driven peptide drug discovery and optimization utilizing decentralized compute (via OpenClaw and the Bittensor network) to identify and optimize novel peptide therapeutics. SN platform → candidate generation → LLC‑based SPVs for de‑risked molecules → preclinical drug development.